Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cell Rep ; 30(9): 2859-2868.e5, 2020 03 03.
Artículo en Inglés | MEDLINE | ID: mdl-32130891

RESUMEN

A key limitation of the widely used CRISPR enzyme S. pyogenes Cas9 is the strict requirement of an NGG protospacer-adjacent motif (PAM) at the target site. This constraint can be limiting for genome editing applications that require precise Cas9 positioning. Recently, two Cas9 variants with a relaxed PAM requirement (NG) have been developed (xCas9 and Cas9-NG), but their activity has been measured at only a small number of endogenous sites. Here, we devise a high-throughput Cas9 pooled competition screen to compare the performance of Cas9 variants at thousands of genomic loci for gene knockout, transcriptional activation, and inhibition. We show that PAM flexibility comes at a substantial cost of decreased DNA targeting and cleavage. Of the PAM-flexible variants, we find that Cas9-NG outperforms xCas9 regardless of genome engineering modality or PAM. Finally, we combine xCas9 mutations with those of Cas9-NG, creating a stronger transcriptional modulator than existing PAM-flexible Cas9 variants.


Asunto(s)
Proteína 9 Asociada a CRISPR/genética , Técnicas de Inactivación de Genes , Variación Genética , Ensayos Analíticos de Alto Rendimiento , Motivos de Nucleótidos/genética , Transcripción Genética , Proteína 9 Asociada a CRISPR/metabolismo , Endonucleasas/metabolismo , Células HEK293 , Humanos , Mutación INDEL/genética , Factores de Tiempo , Activación Transcripcional/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA